Goldman Sachs Group »

Soleno Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.8M 69k 40.25

More positions owned by Goldman Sachs Group

Spdr S&p 500 Etf Tr CMN (SPY)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Ishares Tr CMN (IWM)
Amazon CMN (AMZN)
Nvidia Corporation CMN (NVDA)
Invesco Qqq Tr CMN (QQQ)
Ishares Tr CMN (IVV)
Tesla CMN (TSLA)
Alphabet CMN (GOOGL)
Meta Platforms CMN (META)
Vanguard Index Fds CMN (VOO)
Visa CMN (V)
Ishares Tr CMN (HYG)
Ishares Tr CMN (EFA)

View all positions for Goldman Sachs Group

Top funds holding Soleno Therapeutics

Vivo Capital
Perceptive Advisors
Carlyle
Nantahala Capital Management
Henderson Group
Vanguard Group
Balyasny Asset Management
venBio Select Advisor
Commodore Capital
Ikarian Capital
Frazier Life Sciences Management
Samlyn Capital
Emerald Advisers
Wellington Management Company
Emerald Mutual Fund Advisers, Trust

View all funds holding Soleno Therapeutics